Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_assertion description "[Therapy targeting Vav3 in combination with docetaxel may have practical implications for managing castration-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_assertion evidence source_evidence_literature NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_assertion SIO_000772 23566222 NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_assertion wasDerivedFrom befree-20150227 NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_assertion wasGeneratedBy ECO_0000203 NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP843679.RAl-ZHT6qG-9G5vmWgerYRtNzuuoej4yjeCOOSeFZTNTI130_provenance.